Evaluation of neutrophil–lymphocyte ratio in patients with early-stage mycosis fungoides
- 11 August 2016
- journal article
- research article
- Published by Springer Nature in Annals of Hematology
- Vol. 95 (11) , 1853-1857
Abstract
Neutrophil–lymphocyte ratio (NLR), an indicator of inflammation, has been lately demonstrated as a prognostic factor and an indicator of disease activity in various diseases. However, the effects of NLR have not been investigated in mycosis fungoides (MF) patients yet. The aim of this study is to investigate the relationship between the NLR and treatment demand (systemic PUVA and/or chemotherapy), time to treatment, progression in stage, and time to progression in stage in MF patients. The data of 117 patients, who were followed with the diagnosis of MF at the Department of Dermatology in Istanbul Training and Research Hospital between April 2006 and January 2016, were analyzed retrospectively. The cutoff score for NLR was determined as 2 according to the median NLR level which was 1.96. At the time of diagnosis, the median age of patients was 54 years (range, 21–90) with 62 (53 %) female and 55 (47 %) male. Seventy-seven (65.8 %) patients required treatment during follow-up. Sixty-three (53.8 %) patients showed progression in disease stage. There was no significant difference in treatment demand, time to treatment, progression in stage, and time to progression in stage in patients with a NLR ≥ 2 and NLR < 2 (p = 0.331, 0.987, 0.065, and 0.119, respectively). It seems that there is no association between the NLR and treatment demand, time to treatment, progression in stage, and time to progression in stage in MF patients.Keywords
This publication has 23 references indexed in Scilit:
- The systemic inflammation-based neutrophil–lymphocyte ratio: Experience in patients with cancerCritical Reviews in Oncology/Hematology, 2013
- Prognostic Significance of the Ratio of Absolute Neutrophil Count to Absolute Lymphocyte Count in Classic Hodgkin LymphomaAmerican Journal of Clinical Pathology, 2012
- Assessment of neutrophil-lymphocyte ratio in ulcerative colitis: A promising marker in predicting disease severityClinics and Research in Hepatology and Gastroenterology, 2012
- Neutrophil lymphocyte ratio as a measure of systemic inflammation in prevalent chronic diseases in Asian populationInternational Archives of Medicine, 2012
- Predicting survival for diffuse large B‐cell lymphoma patients using baseline neutrophil/lymphocyte ratioAmerican Journal of Hematology, 2010
- Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 casesBlood, 2009
- Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)Blood, 2007
- EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndromeEuropean Journal of Cancer, 2006
- Inflammation, a Key Event in Cancer DevelopmentMolecular Cancer Research, 2006
- WHO-EORTC classification for cutaneous lymphomasBlood, 2005